Startup Dossier
Tissium
TISSIUM develops biomorphic polymer-based medical devices for tissue reconstruction and repair. Its platform enables sutureless tissue repair across multiple surgical applications, including peripheral nerve repair, hernia repair, and cardiovascular surgery.
active
Typestartup
SectorOther
LocationParis
About
TISSIUM develops biomorphic polymer-based medical devices for tissue reconstruction and repair. Its platform enables sutureless tissue repair across multiple surgical applications, including peripheral nerve repair, hernia repair, and cardiovascular surgery.
Structural DNA
Legal Name
Tissium
SIREN
793166299
Founders & Team
Funding Lineage
Series D
0 investors
€30.0M
Jun 2026
Series D
Cathay Health (Lead)
€49.8M
May 2023
Series C
Cathay Capital (Lead)
€50.0M
Aug 2021
Programs
French Tech Next 40/120
2026Next 402025FT 1202024FT 1202023FT 1202022FT 1202021FT 1202020FT 120
i-Nov
2019Vague 4